CA
NZ
UK
AU
IND
US
…
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
RELX PLC provides information and analytics to professional markets through scientific, technical & medical publishing, legal and risk analytics, and events. Long-term growth may be supported by recurring subscription revenues, expansion of data-and-AI analytics, and digital adoption across customer workflows, which appear to underpin resilient, high-margin cash flows.
Key risks include regulatory and data-privacy scrutiny, competition from alternative content and analytics providers, exposure to cyclical exhibition demand and sensitivity to academic, corporate spending and currency movements.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 2750.00M | 2557.00M | 2295.00M | 2113.00M | 1797.00M |
| Minority interest | -13.00M | -10.00M | -7.00M | 2.00M | 0.00M |
| Net income | 2065.00M | 1934.00M | 1781.00M | 1634.00M | 1471.00M |
| Selling general administrative | 1863.00M | 1846.00M | 1850.00M | 1819.00M | 1630.00M |
| Selling and marketing expenses | 1511.00M | 1470.00M | 1459.00M | 1385.00M | 1197.00M |
| Gross profit | 6109.00M | 6134.00M | 5945.00M | 5508.00M | 4682.00M |
| Reconciled depreciation | 663.00M | 706.00M | 717.00M | 713.00M | 724.00M |
| Ebit | 3023.00M | 2838.00M | 2595.00M | 2323.00M | 1884.00M |
| Ebitda | 3686.00M | 3544.00M | 3312.00M | 3040.00M | 2616.00M |
| Depreciation and amortization | 663.00M | 706.00M | 717.00M | 717.00M | 732.00M |
| Operating income | 2983.00M | 2861.00M | 2682.00M | 2323.00M | 1884.00M |
| Other operating expenses | 6607.00M | 6573.00M | 6479.00M | 6249.00M | 5389.00M |
| Interest expense | 298.00M | 281.00M | 300.00M | 205.00M | 150.00M |
| Tax provision | 672.00M | 613.00M | 507.00M | 481.00M | 326.00M |
| Interest income | 12.00M | 6.00M | 8.00M | 4.00M | 8.00M |
| Net interest income | -258.00M | -276.00M | -293.00M | -201.00M | -142.00M |
| Income tax expense | 672.00M | 613.00M | 507.00M | 481.00M | 326.00M |
| Total revenue | 9590.00M | 9434.00M | 9161.00M | 8553.00M | 7244.00M |
| Total operating expenses | 3126.00M | 3273.00M | 3263.00M | 3204.00M | 2827.00M |
| Cost of revenue | 3481.00M | 3300.00M | 3216.00M | 3045.00M | 2562.00M |
| Total other income expense net | -233.00M | -304.00M | -387.00M | -210.00M | -87.00M |
| Net income from continuing ops | 2078.00M | 1944.00M | 1788.00M | 1632.00M | 1471.00M |
| Net income applicable to common shares | - | - | - | 1634.00M | 1471.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 14757.00M | 15133.00M | 14917.00M | 15829.00M | 13858.00M |
| Intangible assets | 3072.00M | 3164.00M | 3238.00M | 3524.00M | 3304.00M |
| Other current assets | 50.00M | 79.00M | 372.00M | 2426.00M | 1991.00M |
| Total liab | 12367.00M | 11629.00M | 11478.00M | 12075.00M | 10634.00M |
| Total stockholder equity | 2366.00M | 3481.00M | 3460.00M | 3776.00M | 3232.00M |
| Other current liab | 162.00M | 3783.00M | 1546.00M | 300.00M | 241.00M |
| Common stock | 264.00M | 272.00M | 275.00M | 279.00M | 286.00M |
| Capital stock | 264.00M | 272.00M | 275.00M | 279.00M | 286.00M |
| Other liab | - | - | - | 1028.00M | 939.00M |
| Good will | 7930.00M | 8216.00M | 8023.00M | 8388.00M | 7366.00M |
| Other assets | - | - | - | 291.00M | 327.00M |
| Cash | 131.00M | 119.00M | 155.00M | 334.00M | 113.00M |
| Total current liabilities | 5993.00M | 5718.00M | 5490.00M | 5187.00M | 3748.00M |
| Current deferred revenue | - | - | 2297.00M | - | - |
| Net debt | 7203.00M | 6425.00M | 6342.00M | 6396.00M | 6054.00M |
| Short term debt | 1601.00M | 1412.00M | 1313.00M | 870.00M | 232.00M |
| Short long term debt | 1541.00M | 1374.00M | 1256.00M | 803.00M | 163.00M |
| Short long term debt total | 7334.00M | 6544.00M | 6497.00M | 6730.00M | 6167.00M |
| Other stockholder equity | 1973.00M | 883.00M | 1005.00M | 3497.00M | 2946.00M |
| Property plant equipment | - | - | - | 271.00M | 292.00M |
| Total current assets | 2960.00M | 2996.00M | 2874.00M | 3069.00M | 2357.00M |
| Net tangible assets | - | - | - | -8136.00M | -7438.00M |
| Short term investments | - | - | 48.00M | - | - |
| Net receivables | 2468.00M | 2467.00M | 2029.00M | 2405.00M | 1960.00M |
| Long term debt | 5629.00M | 5067.00M | 5100.00M | 5745.00M | 5796.00M |
| Inventory | 311.00M | 331.00M | 318.00M | 309.00M | 253.00M |
| Accounts payable | 4260.00M | 223.00M | 171.00M | 4017.00M | 3275.00M |
| Accumulated other comprehensive income | 129.00M | 2326.00M | 2180.00M | - | - |
| Non currrent assets other | 197.00M | 241.00M | 167.00M | 431.00M | 329.00M |
| Non current assets total | 11797.00M | 12137.00M | 12043.00M | 12760.00M | 11501.00M |
| Capital lease obligations | 97.00M | 103.00M | 141.00M | 182.00M | 208.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -42.00M | -575.00M | -569.00M | -859.00M | -8.00M |
| Change to liabilities | - | - | - | 280.00M | -32.00M |
| Total cashflows from investing activities | -829.00M | -613.00M | -590.00M | -859.00M | -384.00M |
| Net borrowings | 736.00M | 155.00M | -112.00M | 182.00M | -724.00M |
| Total cash from financing activities | -2032.00M | -2064.00M | -2057.00M | -1334.00M | -1606.00M |
| Change to operating activities | - | - | - | - | -148.00M |
| Net income | 2065.00M | 1934.00M | 1781.00M | 2323.00M | 1884.00M |
| Change in cash | 12.00M | -36.00M | -179.00M | 221.00M | 25.00M |
| Begin period cash flow | 119.00M | 155.00M | 334.00M | 113.00M | 88.00M |
| End period cash flow | 131.00M | 119.00M | 155.00M | 334.00M | 113.00M |
| Total cash from operating activities | 2876.00M | 2645.00M | 2478.00M | 2401.00M | 2016.00M |
| Issuance of capital stock | -34.00M | -28.00M | 41.00M | 26.00M | 32.00M |
| Depreciation | 752.00M | 783.00M | 793.00M | 713.00M | 724.00M |
| Other cashflows from investing activities | -464.00M | -385.00M | -419.00M | 33.00M | 20.00M |
| Dividends paid | 1181.00M | 1121.00M | 1059.00M | 983.00M | 920.00M |
| Change to inventory | -101.00M | -83.00M | -90.00M | -103.00M | -13.00M |
| Change to account receivables | 14.00M | -173.00M | -24.00M | -251.00M | -103.00M |
| Sale purchase of stock | -1576.00M | -1075.00M | -850.00M | -550.00M | -1.00M |
| Other cashflows from financing activities | -55.00M | -72.00M | -79.00M | 309.00M | -86.00M |
| Change to netincome | - | - | - | 56.00M | -31.00M |
| Capital expenditures | 21.00M | 20.00M | 30.00M | 436.00M | 337.00M |
| Change in working capital | -63.00M | -146.00M | -115.00M | -74.00M | -148.00M |
| Stock based compensation | 63.00M | 66.00M | 56.00M | 46.00M | 45.00M |
| Other non cash items | 122.00M | 74.00M | 19.00M | -607.00M | -489.00M |
| Free cash flow | 2855.00M | 2625.00M | 2448.00M | 1965.00M | 1679.00M |
Sector: Industrials Industry: Specialty Business Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| RELX Relx PLC ADR |
0.95 2.43% |
40.09 | 20.25 | 16.16 | 6.12 | 37.10 | 5.55 | 14.13 |
| CTAS Cintas Corporation |
1.75 0.80% |
219.82 | 37.19 | 33.11 | 6.39 | 14.93 | 6.73 | 24.37 |
| RLXXF Relx PLC |
0.11 0.27% |
39.80 | 20.12 | 15.38 | 6.08 | 35.32 | 5.43 | 13.82 |
| TRI Thomson Reuters Corporation Common Shares |
1.90 1.63% |
118.25 | 27.00 | 20.92 | 5.68 | 4.12 | 6.20 | 14.50 |
| WTKWY Wolters Kluwer NV |
2.20 2.32% |
97.12 | 30.98 | 26.45 | 6.17 | 15.44 | 6.64 | 21.22 |
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
| Name | Title | Year Born |
|---|---|---|
| Mr. Erik Engstrom | CEO & Exec. Director | 1963 |
| Mr. Nicholas Lawrence Luff | CFO & Exec. Director | 1967 |
| Ms. Kumsal Bayazit Besson | Chief Exec. Officer of Scientific, Technical & Medical | 1974 |
| Mr. Colin Tennant | Head of Investor Relations | NA |
| Mr. Henry Adam Udow | Chief Legal Officer & Company Sec. | 1958 |
| Mr. Paul Abrahams | Head of Corp. Communications | NA |
| Ms. Rosemary Thomson | Chief HR Officer | 1969 |
| Mr. Mark Kelsey | Chief Exec. Officer of Risk | NA |
| Ms. Jelena Sevo | Chief Strategy Officer | NA |
| Mr. Michael Walsh | Chief Exec. Officer of Legal | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...